🔎 Trials Near Me

Home › Type 1 Diabetes › NCT07356089

Twiist Postmarket Surveillance Study for Type 1 Diabetes

RecruitingObservational study

Twiist Postmarket Surveillance Study in Adults and Youth With Type 1 Diabetes

Who can join

Ages 6 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Willing and able to provide informed consent (or a parent or other legally authorized representative)
* Age ≥ 6 years old
* Diagnosis of T1D
* Currently using twiist AID system, with initiation of twiist within 90 days of enrollment
* Willing to only use an insulin approved for the pump
* Residing in United States
* Willing to use twiist in accordance with the user manual
* Willing to have the study use the twiist data and any information that has been provided to Sequel Medtech, LLC or customer support since twiist was started
* Willing to complete surveys at the beginning of the study and then monthly for 12 months
* Willing to be contacted if clarification or further information is needed for any events reported on a survey or to customer support
* Willing to provide medical records or sign a record release for any hospitalizations
* Has cell service or if not, will have access to WIFI at least once a week
* For females, not pregnant or planning pregnancy in the next 12 months
* Able to speak and read English
* Able to obtain documentation of HbA1c result obtained within 6 months prior to twiist initiation

Exclusion Criteria:

* Any form of diabetes other than T1D
* Receiving dialysis for end-stage renal disease

About the study

The goal of this surveillance study is to collect real-world data on adults and youth with type 1 diabetes (T1D) using twiist(TM) for insulin delivery.

What is being tested

Sponsor: Deka Research and Development · Participants: 1,875 · Started: Dec 9, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT07356089

Locations in the U.S.

FloridaJaeb Center for Health Research, Tampa

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.